Total Funding
55
37
Total FundingGrant raised
Growth Score
-1 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
149127
DMK Pharmaceuticals is a privately held, clinical-stage neuroscience company.
- John Dorbin: General Counsel Corporate Secretary
Seth Cohen: Chief Financial Officer
About the Company
DMK Pharmaceuticals help the patients to overcome with central nervous disorders could live their lives in control, rather than being controlled by their addiction, chronic pain, Parkinson's disease, depression, bladder problems - or their treatments.
